Package Leaflet: Information for the User
MINIPRES 1mg Tablets
MINIPRES 2mg Tablets
MINIPRES 5mg Tablets
Prazosin Hydrochloride
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Minipres is indicated for the treatment of high blood pressure in the arteries (arterial hypertension), Raynaud's disease (narrowing of the capillaries in the hands and feet), and for the treatment of symptoms associated with urinary flow obstruction in benign prostatic hyperplasia (BPH).
Do not takeMinipresif:
Warnings and Precautions
Talk to your doctor or pharmacist before starting to take Minipres.
Children and Adolescents
The safety and efficacy of Minipres in the treatment of patients under 18 years of age have not been established.
Minipres is not recommended for use in patients under 18 years of age.
Using Minipres with other Medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
There are some medicines that may interact with Minipres:
Minipres may affect the results of diagnostic tests for pheochromocytoma.
Taking Minipres with Food and Drink
Minipres can be taken at any time of day, preferably with food.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Driving and Using Machines
Do not drive or operate machinery if you feel dizzy after taking this medicine.
Minipres contains Sodium
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medicine indicated by your doctor. If in doubt, consult your doctor or pharmacist again.
Adults
The usual initial dose of Minipres is one 1mg tablet per day, divided into two daily doses. If necessary, your doctor may gradually increase the dose at 4-day intervals, up to a maintenance dose of up to 20mg in the treatment of arterial hypertension. The maintenance dose in the treatment of Raynaud's disease is 4-6mg and in benign prostatic hyperplasia is 4mg. It is recommended that on the first day of treatment, the medication be administered with dinner.
Minipres should be swallowed whole, with the help of a little water. The tablets can be taken orally at any time of day, preferably with food.
If you think the action of the Minipres tablets is too strong or too weak, tell your doctor or pharmacist.
Elderly and Patients with Hepatic Impairment
Your doctor will monitor the dose adjustment.
If you take more Minipres than you should
If for any reason you have taken more Minipres than you should, talk to your doctor or pharmacist immediately or call the Toxicology Information Service. Telephone 91 562 04 20, indicating the medicine and the amount used.
Take the remaining tablets, the box, and the complete packaging so that hospital staff can easily identify the medicine you have taken.
If you forget to take Minipres
If you forget to take a dose, take the next scheduled dose at the correct time.
Do not take a double dose to make up for forgotten doses.
If you stop taking Minipres
Do not stop taking Minipres unless your doctor tells you to. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common side effects (affect less than 1 in 10 people):
Uncommon side effects (affect less than 1 in 100 people):
Rare side effects (affect less than 1 in 1,000 people):
If any of these side effects get serious, or if you notice any side effects not listed in this leaflet, please tell your doctor.
Reporting of side effects:
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not store above 30°C.
Do not use this medicine after the expiry date which is stated on the packaging and outer carton, after EXP. The expiry date is the last day of the month stated.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Composition of Minipres
The active substance is prazosin.
The other ingredients (excipients) are: microcrystalline cellulose, calcium hydrogen phosphate, maize starch, magnesium stearate and sodium lauryl sulfate.
The 1mg Minipres tablets contain 1mg of prazosin as prazosin hydrochloride.
The 2mg Minipres tablets contain 2mg of prazosin as prazosin hydrochloride.
The 5mg Minipres tablets contain 5mg of prazosin as prazosin hydrochloride.
Appearance of the Product and Contents of the Pack
The 1mg Minipres tablets are white, oblong, with a score line on one face and engraved with "M6" on the same face.
The 2mg Minipres tablets are white, round, with a score line on one face and engraved with "M7" on the opposite face.
The 5mg Minipres tablets are white, rhomboid, with a score line on one face and engraved with "M8" on the opposite face.
The 1mg and 2mg Minipres tablets are available in packs with blisters containing 60 tablets.
The 5mg Minipres tablets are available in packs with blisters containing 30 tablets.
Marketing Authorisation Holder
Pfizer, S.L.
Avda. de Europa, 20B – Parque Empresarial La Moraleja
28108 Alcobendas (Madrid)
Manufacturer
FARMASIERRA MANUFACTURING, S.L.
Ctra. N-I, Km 26,200
28709 San Sebastián de los Reyes (Madrid).
Date of the last revision of this leaflet: October 2023
Detailed and up-to-date information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of MINIPRES 2 mg TABLETS in October, 2025 is around 4.67 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.